Nejla Ghane1,2, Miranda M Broadney1,3, Elisabeth K Davis1, Robert W Trenschel1, Shavonne M Collins4, Sheila M Brady1,3, Jack A Yanovski1. 1. Section on Growth and Obesity, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland. 2. Office of Intramural Training and Education, Office of the Director, NIH, Bethesda, Maryland. 3. Office of the Clinical Director, Division of Intramural Research, NICHD, NIH, Bethesda, Maryland. 4. Meharry Medical College, Nashville, Tennessee.
Abstract
Few studies have assessed the accuracy of the FreeStyle Libre Pro (FLP) continuous glucose monitor for estimating plasma glucose (PG) in non-diabetic children. OBJECTIVE: Determine the accuracy of FLP compared to PG during OGTT in healthy children. SUBJECTS:Children (7-11.99 years) with healthy weight and overweight/obesity (n = 33; 52% male). METHODS: Participants wore the FLP before and during a 2-hour OGTT; PG was measured at 30 minutes intervals. Potential systematic- and magnitude-related biases for FLP vs PG were examined. RESULTS:FLP 15-minute averages and PG were correlated at most timepoints during OGTT (r2 = 0.35-0.69, P's < .001 for time point 30-120 minutes) and for PG area under the curve (AUC) (r2 = 0.65, P < .0001). There were no systematic biases as assessed by Bland-Altman analyses for FLP AUC or for FLP at each OGTT timepoint. However, for fasting glucose, a significant magnitude bias was noted (r2 = 0.38, P < .001), such that lower PG was underestimated, and higher PG was overestimated by FLP readings; further, there was poor correlation between fasting PG and FLP (r2 = 0.06, P = .22). BMIz was also associated with FLP accuracy: FLP overestimated PG in children with low BMIz and underestimated PG in those with overweight/obesity for OGTT AUC and OGTT PG at baseline, 60, and 120 minutes (all P's ≤ .015). No adverse events occurred with FLP. CONCLUSIONS: Among children without diabetes, the FLP was well tolerated and correlated with post-OGTT glucose, but had magnitude bias affecting fasting glucose and appeared to underestimate plasma glucose in those with overweight/obesity. These results suggest potential limitations for the utility of the FLP for research.
RCT Entities:
Few studies have assessed the accuracy of the FreeStyle Libre Pro (FLP) continuous glucose monitor for estimating plasma glucose (PG) in non-diabeticchildren. OBJECTIVE: Determine the accuracy of FLP compared to PG during OGTT in healthy children. SUBJECTS:Children (7-11.99 years) with healthy weight and overweight/obesity (n = 33; 52% male). METHODS:Participants wore the FLP before and during a 2-hour OGTT; PG was measured at 30 minutes intervals. Potential systematic- and magnitude-related biases for FLP vs PG were examined. RESULTS:FLP 15-minute averages and PG were correlated at most timepoints during OGTT (r2 = 0.35-0.69, P's < .001 for time point 30-120 minutes) and for PG area under the curve (AUC) (r2 = 0.65, P < .0001). There were no systematic biases as assessed by Bland-Altman analyses for FLP AUC or for FLP at each OGTT timepoint. However, for fasting glucose, a significant magnitude bias was noted (r2 = 0.38, P < .001), such that lower PG was underestimated, and higher PG was overestimated by FLP readings; further, there was poor correlation between fasting PG and FLP (r2 = 0.06, P = .22). BMIz was also associated with FLP accuracy: FLP overestimated PG in children with low BMIz and underestimated PG in those with overweight/obesity for OGTT AUC and OGTT PG at baseline, 60, and 120 minutes (all P's ≤ .015). No adverse events occurred with FLP. CONCLUSIONS: Among children without diabetes, the FLP was well tolerated and correlated with post-OGTT glucose, but had magnitude bias affecting fasting glucose and appeared to underestimate plasma glucose in those with overweight/obesity. These results suggest potential limitations for the utility of the FLP for research.
Authors: J A Coss-Bu; L S Jefferson; S Stone-McCord; C N Ou; C Watrin; R Sachdeva; K C Copeland Journal: Diabetes Res Clin Pract Date: 1999-06 Impact factor: 5.602
Authors: Roger S Mazze; Ellie Strock; David Wesley; Sarah Borgman; Blaine Morgan; Richard Bergenstal; Robert Cuddihy Journal: Diabetes Technol Ther Date: 2008-06 Impact factor: 6.118
Authors: Guy G Massa; Inge Gys; Anniek Op 't Eyndt; Esmiralda Bevilacqua; Anne Wijnands; Peter Declercq; Renate Zeevaert Journal: Horm Res Paediatr Date: 2018-03-27 Impact factor: 2.852
Authors: T Battelino; I Conget; B Olsen; I Schütz-Fuhrmann; E Hommel; R Hoogma; U Schierloh; N Sulli; J Bolinder Journal: Diabetologia Date: 2012-09-11 Impact factor: 10.122
Authors: Elizabeth Hegedus; Sarah-Jeanne Salvy; Choo Phei Wee; Monica Naguib; Jennifer K Raymond; D Steven Fox; Alaina P Vidmar Journal: Obes Res Clin Pract Date: 2021-09-02 Impact factor: 5.214